- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2010
- Public Summary Document (PSD) March 2010 PBAC Meeting - PDF
Adalimumab – March 2010
Adalimumab, injection, 20 mg in 0.4 mL, 40 mg in 0.8 mL, pre-filled syringe, Humira® - March 2010
Last updated
2 July 2010